Biggest News Aggregation in the World
📰 Trial Program News

Page 20 - Trial Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trial Program. Real-time updates on events, politics, business and more.

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

Dupixent® late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic for... | May 21, 2023
France General United States Surya Bhatt Sally Bain Felix Lauscher Sharon Chen

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sanofi - Aventis Groupe: Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic
France General United States Eva Schaefer Jansen Sandrine Guendoul Surya Bhatt Gewinn Nur

Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of Medicine

Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant reduction in moderate or severe acute exacerbations by 30% compared to placebo Dupixent is the... | May 21, 2023
United States France General Nathalie Pham Eva Schaefer Jansen Tarik Elgoutni Sally Bain

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science